General
Preferred name
ganirelix
Synonyms
Orgalutran ()
GANIRELIX ACETATE ()
Ganirelix (acetate) ()
Ganirest ()
Ganirelix acetate (Antagon) ()
Ganirelix ()
Ganirelix Acetate Injection ()
RS-26306-298 ()
RS-26306 ()
P&D ID
PD009230
CAS
124904-93-4
129311-55-3
123246-29-7
Tags
available
drug
Approved by
EMA
FDA
First approval
1999
Drug Status
approved
Drug indication
Gonad-Stimulating Principle
Ovulation dysfunction
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
35
Properties
(calculated by RDKit )
Molecular Weight
1568.84
Hydrogen Bond Acceptors
16
Hydrogen Bond Donors
16
Rotatable Bonds
44
Ring Count
6
Aromatic Ring Count
5
cLogP
2.27
TPSA
451.49
Fraction CSP3
0.5
Chiral centers
10.0
Largest ring
6.0
QED
0.02
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Biosynthetic Origin
Peptide (Ribosomal)
Therapeutic Indication
Ovulation
Therapeutic Class
Hormone Therapy
Abortifacient Agents
Pathway
GPCR/G protein
Target
GNRH Receptor
Source data
